RESULTS OF SURGICAL TREATMENT FOR MEDULLOBLASTOMA IN CHILDREN AT THE NATIONAL CHILDREN'S HOSPITAL

Quốc Huy Nguyễn, Đại Hà Dương, Quỳnh Trang Phạm, Tuấn Anh Lê

Main Article Content

Abstract

Objectives: To describe the clinical and imaging diagnosis characteristics and to evaluate surgical outcomes of posterior fossa medulloblastoma in children at Vietnam National Children’s Hospital. Methods: A retrospective descriptive study of 32 pediatric patients diagnosed and surgically treated for medulloblastoma from January 1 to December 31, 2024. Results: Mean age was 6.65 ± 3.96 years, male/female ratio 1.13. The most common symptoms were headache (75%), vomiting (75%), and cerebellar syndrome (65.6%). Tumors were mostly located in the vermis (78.1%), measured 3–5 cm (62.5%), showed strong contrast enhancement (93.8%), and were associated with hydrocephalus (93.8%). Gross total resection was achieved in 53.1%. Postoperative complications included motor deficits (34.4%), mutism (15.6%), and meningitis (15.6%). The 3-month postoperative mortality was 31.2%. MRI follow-up showed residual tumor in 27.3% and spinal dissemination in 22.7%. Conclusions: Posterior fossa medulloblastoma in children typically presents with signs of intracranial hypertension and cerebellar syndrome. Surgery remains crucial in management, but postoperative complications and mortality remain high. Early detection and multimodal therapy are essential to improve outcomes.

Article Details

References

1. Albright AL, Wisoff JH, Zeltzer PM, Boyett JM, Rorke LB, Stanley P. Effects of medulloblastoma resections on outcome in children: a report from the Children’s Cancer Group. Neurosurgery. 1996 Feb;38(2):265–71.
2. Trần Văn Học, Nguyễn Văn Thắng, Nguyễn Thanh Liêm: Kết quả điều trị u nguyên tủy bào ở trẻ em tại Bệnh viện Nhi Trung ương - Tạp chí Nghiên cứu y học, quyển 80, số 3, tháng 6, 2012, Tr 52-58.
3. The Treatment Outcomes in Children with Medulloblastoma | The Journal of Pediatric Academy [Internet]. [cited 2025 Aug 22]. Available from: https://www. jpediatricacademy. com/index.php/jpa/article/view/88
4. Wong TT, Liu YL, Ho DMT, Chang KP, Liang ML, Chen HH, et al. Factors affecting survival of medulloblastoma in children: the changing concept of management. Childs Nerv Syst. 2015 Oct;31(10):1687–98.
5. Avula S, Mallucci C, Kumar R, Pizer B. Posterior fossa syndrome following brain tumour resection: review of pathophysiology and a new hypothesis on its pathogenesis. Childs Nerv Syst. 2015 Oct;31(10):1859–67.
6. Ramaswamy V, Remke M, Bouffet E, Faria CC, Perreault S, Cho YJ, et al. Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis. Lancet Oncol. 2013 Nov;14(12):1200–7.
7. Diaz-Coronado RY, Alcasabas APA, Baticulon RE, Hamid SA, Omran N, Sharafeldin H, et al. Outcomes of pediatric medulloblastoma in low- and middle-income countries: A retrospective analysis of 335 cases from 8 countries. Neuro Oncol Adv. 2025 Jan 1;7(1):vdaf086.
8. Salceda-Rivera V, Tejocote-Romero I, Osorio DS, Bellido-Magaña R, López-Facundo A, Anaya-Aguirre SE, et al. Impact of treatment and clinical characteristics on the survival of children with medulloblastoma in Mexico. Front Oncol [Internet]. 2024 May 2 [cited 2025 Aug 31];14. Available from: https://www.frontiersin.org/journals/ oncology/articles/10.3389/fonc.2024.1376574/full